GENE ONLINE|News &
Opinion
Blog

NDA
Trials & Approvals FDA
Otsuka and Lundbeck’s Treatment for Schizophrenia and Bipolar I NDA Accepted by the FDA
2022-09-13
In-Depth Hearing Loss
Fennec Submits Hearing Loss Drug for Third Time After Prior FDA Approval Rejections
2022-04-28
Trials & Approvals Depression
Biogen, Sage Pursue 2022 Filing for Depression Therapy, Zuranolone
2021-10-20
NDA
Daiichi Sankyo Files NDA for a New Oncolytic Virus in Japan
2021-01-07
Liver Cancer
China’s Regulatory Body Accepts Application for First Selective Internal Radiation Therapy for HCC
2020-11-29
Ranking & Reports
Weekly Top 5 in China (0127-0202)
2019-01-29
Trials & Approvals Anti-PD-1
Innovent reports clinical trial results of its anti-PD-1 monoclonal antibody
2018-09-26
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top